These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 28033351)

  • 1. Association of C1q/TNF-Related Protein-3 (CTRP3) and CTRP13 Serum Levels with Coronary Artery Disease in Subjects with and without Type 2 Diabetes Mellitus.
    Fadaei R; Moradi N; Baratchian M; Aghajani H; Malek M; Fazaeli AA; Fallah S
    PLoS One; 2016; 11(12):e0168773. PubMed ID: 28033351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating C1q complement/TNF-related protein (CTRP) 1, CTRP9, CTRP12 and CTRP13 concentrations in Type 2 diabetes mellitus: In vivo regulation by glucose.
    Bai B; Ban B; Liu Z; Zhang MM; Tan BK; Chen J
    PLoS One; 2017; 12(2):e0172271. PubMed ID: 28207876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower serum levels of Meteorin-like/Subfatin in patients with coronary artery disease and type 2 diabetes mellitus are negatively associated with insulin resistance and inflammatory cytokines.
    Dadmanesh M; Aghajani H; Fadaei R; Ghorban K
    PLoS One; 2018; 13(9):e0204180. PubMed ID: 30212581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of CTRP3 in diabetic nephropathy and its relationship with insulin resistance and kidney function.
    Moradi N; Fadaei R; Khamseh ME; Nobakht A; Rezaei MJ; Aliakbary F; Vatannejad A; Hosseini J
    PLoS One; 2019; 14(4):e0215617. PubMed ID: 31009504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of CTRP3, CTRP9 and MCP-1 for the evaluation of T2DM associated coronary artery disease in Egyptian postmenopausal females.
    Ahmed SF; Shabayek MI; Abdel Ghany ME; El-Hefnawy MH; El-Mesallamy HO
    PLoS One; 2018; 13(12):e0208038. PubMed ID: 30557342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased Epicardial
    Matloch Z; Mraz M; Kasperova BJ; Kratochvilova H; Svoboda P; Pleyerova I; Reznickova K; Norman S; Hlavacek D; Mahrik J; Ivak P; Lacinova Z; Netuka I; Haluzik M
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Circulating Levels of Complement-C1q/TNF-Related Protein 13 (CTRP13) in Patients with Type 2 Diabetes and its Association with Insulin Resistance.
    Afrookhteh A; Emamgholipour S; Alipoor B; Moradi N; Meshkani R; Nasli-Esfahani E; Rahimipour A; Shanaki M
    Clin Lab; 2017 Feb; 63(2):327-333. PubMed ID: 28182339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of C1q/TNF-related protein-3 in inflammatory bowel disease patients and its inverse association with inflammatory cytokines and insulin resistance.
    Mohamadinarab M; Ahmadi R; Gholamrezayi A; Rahvar F; Naghdalipour M; Setayesh L; Moradi N; Fadaei R; Chamani E; Tavakoli T; Esteghamati A
    IUBMB Life; 2020 Aug; 72(8):1698-1704. PubMed ID: 32311832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Circulating CTRP13 in Type 2 Diabetes and Non-Alcoholic Fatty Liver Patients.
    Shanaki M; Fadaei R; Moradi N; Emamgholipour S; Poustchi H
    PLoS One; 2016; 11(12):e0168082. PubMed ID: 27936230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating Levels of C1q/TNF-Related Protein 3 (CTRP3) and CTRP9 in Gestational Diabetes and Their Association with Insulin Resistance and Inflammatory Cytokines.
    Fadaei R; Goodarzi G; Yarahmadi S; Allahyari P; Fallah S; Moradi N
    Lab Med; 2023 May; 54(3):262-269. PubMed ID: 36219707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower circulating levels of CTRP12 and CTRP13 in polycystic ovarian syndrome: Irrespective of obesity.
    Shanaki M; Moradi N; Fadaei R; Zandieh Z; Shabani P; Vatannejad A
    PLoS One; 2018; 13(12):e0208059. PubMed ID: 30540803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low serum CTRP3 levels are associated with nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
    Zhang J; Zhang B; Cheng Y; Xu J
    Cytokine; 2018 Jun; 106():131-135. PubMed ID: 29113741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of C1q/TNF-related protein-3 (CTRP3) in serum of patients with gestational diabetes mellitus and its relationship with insulin resistance.
    Li JY; Wu GM; Hou Z; Cao YM
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5702-5710. PubMed ID: 29272006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of circulating CTRP9 with soluble adhesion molecules and inflammatory markers in patients with type 2 diabetes mellitus and coronary artery disease.
    Moradi N; Fadaei R; Emamgholipour S; Kazemian E; Panahi G; Vahedi S; Saed L; Fallah S
    PLoS One; 2018; 13(1):e0192159. PubMed ID: 29381773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement c1q tumor necrosis factor-related protein 3 a novel adipokine, protect against diabetes mellitus in young adult Egyptians.
    Elsaid HH; Elgohary MN; Elshabrawy AM
    Diabetes Metab Syndr; 2019; 13(1):434-438. PubMed ID: 30641739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum protein signature of coronary artery disease in type 2 diabetes mellitus.
    Adela R; Reddy PNC; Ghosh TS; Aggarwal S; Yadav AK; Das B; Banerjee SK
    J Transl Med; 2019 Jan; 17(1):17. PubMed ID: 30674322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased serum levels of CTRP12/adipolin in patients with coronary artery disease in relation to inflammatory cytokines and insulin resistance.
    Fadaei R; Moradi N; Kazemi T; Chamani E; Azdaki N; Moezibady SA; Shahmohamadnejad S; Fallah S
    Cytokine; 2019 Jan; 113():326-331. PubMed ID: 30337217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating levels of CTRP3 in patients with type 2 diabetes mellitus compared to controls: A systematic review and meta-analysis.
    Moradi N; Najafi M; Sharma T; Fallah S; Koushki M; Peterson JM; Meyre D; Fadaei R
    Diabetes Res Clin Pract; 2020 Nov; 169():108453. PubMed ID: 32949652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased circulating CTRP3 levels in acute and chronic cardiovascular patients.
    Schmid A; Pankuweit S; Vlacil AK; Koch S; Berge B; Gajawada P; Richter M; Troidl K; Schieffer B; Schäffler A; Grote K
    J Mol Med (Berl); 2024 May; 102(5):667-677. PubMed ID: 38436713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C1q/TNF-related protein 3 (CTRP3) and 9 (CTRP9) concentrations are decreased in patients with heart failure and are associated with increased morbidity and mortality.
    Gao C; Zhao S; Lian K; Mi B; Si R; Tan Z; Fu F; Wang S; Wang R; Ma X; Tao L
    BMC Cardiovasc Disord; 2019 Jun; 19(1):139. PubMed ID: 31182031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.